Ionis Pharmaceuticals INC (IONS) — SC 13G/A Filings
All SC 13G/A filings from Ionis Pharmaceuticals INC. Browse 6 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (6)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
-
Vanguard Amends Ionis Pharma Stake, Maintains Passive Ownership
— Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, indicating its ownership of Ionis Pharmaceuticals Inc. common stock -
BB Biotech AG Amends IONIS PHARMACEUTICALS Stake
— Feb 13, 2024 Risk: low
BB Biotech AG, a Swiss investment company, filed an amended Schedule 13G/A on February 13, 2024, indicating a change in its beneficial ownership of IONIS PHARMA -
FMR LLC & Abigail Johnson Hold 15% Stake in Ionis Pharma
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its CEO, Abigail P. Johnson, have updated their ownership stake in IONIS PHARMACEUTICALS INC. As of February 9, 2024, they -
BlackRock Amends Ionis Pharma Stake as of Dec 31, 2023
— Jan 26, 2024
BlackRock Inc. has updated its ownership stake in Ionis Pharmaceuticals Inc. as of December 31, 2023, through an SC 13G/A filing. This amendment (Amendment No.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX